HomeChatAlertsCalendarScreenerWatchlistsFiles
Docs
Sign upJoinLog inLogin

BioCorRx Inc. (BICX) stock profile

BioCorRx Inc. (BICX), through its various operations, is dedicated to creating and delivering therapeutic solutions for individuals struggling with substance dependence and related health conditions across the United States. Among its core offerings is the BioCorRx recovery program, an innovative, non-addictive treatment model. This program uniquely combines proprietary naltrexone implants with extensive counseling services to support patient recovery. Additionally, the company provides the UnCraveRx weight management program, a medically supported initiative designed to curb food cravings. This program integrates pharmacological assistance with readily available virtual support focusing on lifestyle adjustments, fitness, and nutritional guidance. Looking to the future, BioCorRx is actively advancing its product pipeline. This includes BICX101, an injectable naltrexone product, and BICX104, an implantable naltrexone device, both currently under development for the specific treatment of opioid addiction and alcoholism. The company's programs are made available to patients through a network of healthcare providers, independent licensed clinics, and other qualified healthcare professionals. Originally established as Fresh Start Private Management, Inc., the organization officially rebranded as BioCorRx Inc. in January 2014. Its corporate headquarters are situated in Anaheim, California.

Key facts

SymbolBICX
ExchangeOTC
SectorHealthcare
IndustryMedical - Care Facilities
CEOLourdes Felix
Employees3
HeadquartersAnaheim, CA, US
IPO2010-08-31
Websitewww.biocorrx.com

Explore BICX on Vantafin

  • BioCorRx Inc. Overview
  • BioCorRx Inc. Financials
  • BioCorRx Inc. News
  • BioCorRx Inc. Events
  • BioCorRx Inc. SEC filings
  • BioCorRx Inc. Insider transactions
  • BioCorRx Inc. Transcripts

Frequently asked questions

What does BioCorRx Inc. (BICX) do?
BioCorRx Inc. (BICX), through its various operations, is dedicated to creating and delivering therapeutic solutions for individuals struggling with substance dependence and related health conditions across the United States. Among its core offerings is the BioCorRx recovery program, an innovative, non-addictive treatment model. This program uniquely combines proprietary naltrexone implants with extensive counseling services to support patient recovery. Additionally, the company provides the UnCraveRx weight management program, a medically supported initiative designed to curb food cravings. This program integrates pharmacological assistance with readily available virtual support focusing on lifestyle adjustments, fitness, and nutritional guidance. Looking to the future, BioCorRx is actively advancing its product pipeline. This includes BICX101, an injectable naltrexone product, and BICX104, an implantable naltrexone device, both currently under development for the specific treatment of opioid addiction and alcoholism. The company's programs are made available to patients through a network of healthcare providers, independent licensed clinics, and other qualified healthcare professionals. Originally established as Fresh Start Private Management, Inc., the organization officially rebranded as BioCorRx Inc. in January 2014. Its corporate headquarters are situated in Anaheim, California.
Where is BICX stock listed?
BioCorRx Inc. trades under the ticker BICX on OTC.
How can I research BICX's financials and filings?
Vantafin provides BioCorRx Inc.'s income statement, balance sheet and cash-flow data, SEC filings, earnings-call transcripts, and insider & institutional ownership on the BICX profile.